Three-part, phase IIb trial of controlled-release levodopa/carbidopa in patients with advanced Parkinson's disease.
Phase of Trial: Phase II
Latest Information Update: 04 Apr 2016
Price : $35 *
At a glance
- Drugs Levodopa/carbidopa (Primary) ; Levodopa
- Indications Parkinson's disease
- Focus Therapeutic Use
- 04 Apr 2016 Primary endpoint (Off time) has been met, according to an Intech Pharma media release.
- 16 Jun 2013 Results presented at the 17th International Congress of Parkinson's Disease and Movement Disorders.
- 24 Oct 2012 New trial record
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History